Here’s Why Now Is a Good Time to Get Greedy With Canopy Growth (TSX:WEED) Stock!

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) may have just put in a bottom with the first decent quarter in a long time!

| More on:
edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

The cannabis trade dried up a long time ago. But that’s exactly why I think Canopy Growth (TSX:WEED)(NYSE:CGC), Canada’s top cannabis kingpin and the “safest” way to play the stomach-churning industry, is now worthy of your investment dollars. To make big money as an investor, you’ve got to be like Warren Buffett and be greedy while others are fearful (and vice versa!) and the rules still apply to the crazy, fast-moving world of marijuana!

Cannabis crashes (or corrections) are nothing new. If you sold on the last few meltdowns in Canopy, you lost out on a sharp rebound and multi-bagger gains that followed. While the recent sell-off is more violent, with Canopy and Aurora Cannabis stock plunging over 70% and 85%, respectively, from peak to trough, I think that in the grander scheme of things that the current downfall will be dwarfed by upward moves over the next decade and beyond.

While it’s impossible to tell if we’re near a bottom, Canopy’s latest results were encouraging — a sign that there’s still life (and opportunity) within the pot space, which most have already given up on.

Canopy soars on better-than-feared third-quarter numbers

Last week, Canopy pulled the curtain on results that weren’t as bad as what many were expecting, given the company has been making a habit of missing the mark with wider-than-expected losses. The stock popped 16% in a single trading session and could mark the start of a sustained rally back to all-time highs.

The third quarter was supposed to be the eighth consecutive miss, marking two straight years of quarterly misses, but Canopy pulled off the unthinkable with EPS losses of $0.35, beating the consensus estimate of an EPS loss of $0.49.

While the battle with the black market wages on in what I see as an eventual race to the bottom, Canopy still managed to grow net revenues by 62% quarter over quarter. That’s still incredible growth in an industry that I think still has plenty of gas left in the tank. With Canopy Growth stock currently trading at 1.9 times book and 26.3 times sales, I see the budding producer as a bargain compared to most other hyper-growth stocks out there with P/S multiples north of 40.

Gross margins crept higher thanks in part to higher-margin consumer product sales. And with more high-margin products (like edibles) that could prop margins up further as they become more widely available, I wouldn’t rule out continued margin expansion, even as the broader industry looks to sacrifice margins to gain business lost to the black market.

Management also expects to see gross margins jump to 40% over the near term, as a result of the “Cannabis 2.0” tailwind and inventory management initiatives to prevent future markdowns.

Profitability may seem like a pipe dream for Canopy, but I think it’s on the right track to sustainably moving into the green within five years. Management learned from its past mistakes and could evolve to become a leader in the space with Constellation Brands as its dance partner.

Further volatility is undoubtedly expected from Canopy (and the industry) moving forward, but if you’re able to buy and forget the roller-coaster ride of a stock, now may be an opportune time while shares remain cheap and out of the radar of the momentum-chasing speculators who’ve since moved on to greener pastures.

Stay hungry. Stay Foolish.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joey Frenette has no position in any of the stocks mentioned. The Motley Fool recommends Constellation Brands.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »